# FDA recall D-0130-2023

> **Pine Pharmaceuticals, LLC** · Class II · drug recall initiated 2022-12-22.

## Product

Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1

## Reason for recall

CGMP Deviations: Raw material recalled by repackager, due to discoloration.

## Distribution

Nationwide to medical facilities.

## Key facts

- **Recall number:** D-0130-2023
- **Recalling firm:** Pine Pharmaceuticals, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-22
- **Report date:** 2023-01-11
- **Termination date:** 2023-05-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Tonawanda, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0130-2023

## Citation

> AI Analytics. FDA recall D-0130-2023. Retrieved 2026-07-19 from https://api.ai-analytics.org/recall/D-0130-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*